Skip to content

BMC Medicine

ISSN 1741-7015

5 papers in the library · 82 citations · publishing 2018-2026

Papers

Sort Most recent Most cited

The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancer

BMC Medicine July 6, 2026 Hannah Adler, Rebecca Filipic, Dr Maria Gonzalez et al.

BACKGROUND: Existential distress is commonly experienced by people with cancer, yet there are limited treatment options. The therapeutic potential for psychedelic-assisted therapy (PAT) utilising psilocybin for this cohort is underexplored, with emerging literature showing clinical improvements in wellbeing. In Australia there is limited knowledge on healthcare professionals' (HCPs') attitudes,...

Understanding experiences of psychedelic treatments for eating disorders: a meta-synthesis of qualitative studies.

BMC Medicine May 19, 2026 Rebecca Morris, Ayse Gundogan, Vanessa Lawrence et al.

Eating disorders (EDs) have complex presentations with high rates of comorbidities and low recovery rates. Current treatment options often lack sufficiency in improving ED symptoms. Psychedelic-assisted therapies represent a novel treatment approach for the treatment of EDs, with research documenting preliminary positive evidence. However, psychedelics have their own challenges and risks which...

Efficacy and safety of esketamine for "treatment resistant depression": registered report for a systematic review with an individual patient data meta-analysis of randomized, double-blind, placebo-controlled trials.

BMC Medicine November 28, 2025 Florian Naudet, Claude Pellen, Liviu A Fodor et al. 5 citations

In 2019, the FDA and EMA approved intranasal esketamine for treatment-resistant depression (TRD). The current study re-evaluated its efficacy and safety. This registered report presents a systematic review and individual patient data (IPD) meta-analysis of double-blind, randomised, placebo-controlled trials (RCTs) assessing intranasal esketamine for TRD. Two reviewers independently screened...

The effects of telehealth-delivered mindfulness meditation, cognitive therapy, and behavioral activation for chronic low back pain: a randomized clinical trial.

BMC Medicine April 12, 2024 Melissa A Day, Marcia A Ciol, M Elena Mendoza et al. 9 citations

Chronic low back pain (CLBP) is a significant problem affecting millions of people worldwide. Three widely implemented psychological techniques used for CLBP management are cognitive therapy (CT), mindfulness meditation (MM), and behavioral activation (BA). This study aimed to evaluate the relative immediate (pre- to post-treatment) and longer term (pre-treatment to 3- and 6-month follow-ups)...

Near-death experiences, attacks by family members, and absence of health care in their home countries affect the quality of life of refugee women in Germany: a multi-region, cross-sectional, gender-sensitive study

BMC Medicine February 1, 2018 J. Jesuthasan, E. Sönmez, I. Abels et al. 68 citations

BackgroundThe year 2016 has marked the highest number of displaced people worldwide on record. A large number of these refugees are women, yet little is known about their specific situation and the hurdles they have to face during their journey. Herein, we investigated whether sociodemographic characteristics and traumatic experiences in the home country and during the flight affected the...